Statistics about Health, Pharma & Medtech in United States
Statistics
- U.S. average invoice price increase for oncology brands 2012-2017
- Number of cancer drugs by cost and number of patients U.S. 2017
- Number of medicines in development for heart disease and stroke by type 2018
- Major concerns among adults regarding personalized medicine in the U.S. in 2018
- Reactions among U.S. adults to description of personalized medicine 2018
- Utilization of orphan drugs in the U.S. from 2012 to 2014, by usage type
- Cumulative price change of orphan drugs in the U.S. 2012-2014
- Percentage chronic therapy dispensed as 90 day prescriptions 2013-2020
- Share of 90 day prescriptions that are mail or retail dispensed 2013-2020
- Antibiotic treatment avoidance among U.S. adults with bronchitis 2008-2012, by region
- Patients receiving the recommended antibiotic treatment U.S. 2010-2011, by age
- Unnecessary antibiotic use for acute respiratory conditions in the U.S. 2015, by age
- Percentage of unnecessary antibiotic prescriptions in the U.S. in 2015, by age
- Percentage of unnecessary antibiotic prescriptions in the U.S. 2015
- Number of ANDA approvals in U.S. 2015-2017, by type
- Generic market share value change worldwide 2006 vs. 2016, by region
- Generic market share change in unit volume worldwide 2006 vs. 2016, by region
- Flow of payments for 3,000 USD HIV medication with patient coinsurance U.S. 2017
- U.S. flow of payments for a 100 USD medication with patient copayment 2017
- Opioid epidemic negative impact on local economies and job growth U.S. 2018
- Pain medication abuse as a community problem according to Americans 2018
- U.S. legal medical marijuana patients rate by state 2018
- Addictiveness comparison marijuana vs. prescription medicine U.S. 2017
- Side-effects comparison marijuana vs. prescription medicine U.S. 2017
- Share of older U.S. adults who would ask a health provider about marijuana 2017
- Pain treatment effectiveness marijuana vs. prescription medicine U.S. 2017
- Share of older U.S. adults who felt medical marijuana provides pain relief as of 2017
- Price disparities for Zetia - U.S. and international 2017
- Price disparities for top product Tamiflu - U.S. and international 2017
- Price disparities for top product Nasonex - U.S. and international 2017
- U.S. physician perceived negative side effects of medical cannabis as of 2017
- U.S. medical cannabis physician perceived benefits as of 2017
- U.S. medical cannabis patient-selected most important benefits as of 2017
- U.S. medical cannabis patient perceptions of cannabis benefits 2017
- U.S. NIH investments in therapeutic cannabis research FY 2015
- U.S. NIH investments in cannabis research FY 2015
- Share of clinical trials investigating cannabis in the U.S. 2016, by therapy area
- Decline in daily drug doses prescribed in states with medical cannabis laws in 2016
- Investment in cannabis companies in the U.S. 2017
- Reasons for consuming cannabis among U.S. adults 2017, by gender
- Legal cannabis industry investments in the U.S. 2017, by sector
- U.S. adults who would recommend medical cannabis to a friend 2017, by age group
- U.S. medical cannabis market revenue forecast by state 2020
- U.S. medical cannabis market revenue by state 2016
- Annual daily drug doses per doctor in states with medical cannabis laws in 2016
- Revenue as a part of R&D spending for select cancer drugs 2017
- Revenue since approval for select cancer drugs 2017
- Total R&D costs including costs of capital for select cancer drugs 2017
- Total R&D costs of select cancer drugs 2017
- High availability of heroin in U.S. 2010 and 2017, by region
- Top CPDs dispensed in billion dosage units in the U.S. 2011-2016
- Top CPDs written in million prescriptions in U.S. 2011-2016
- Time from R&D start to approval of select cancer drugs 2017
- Start up cost breakdown for medical and recreational marijuana retailers U.S. 2017
- MMJ dispensary annual revenue U.S. 2017, by state
- Potential size of new medical marijuana markets in U.S. 2017, by state
- Revenue, expenses and startup costs for medical marijuana dispensaries U.S. 2017
- Common Medicaid respiratory agent prescriptions by product 2016-2017
- Top U.S. oncology products by revenue in 2016
- Opioid prescription regimen for short term medical conditions U.S. 2015
- Medication-assisted treatment prevalence of insured persons U.S. 2010-2016, by type
- Opioid use disorder rate in commercially-insured persons U.S. 2016, by gender and age
- Opioid prescriptions for U.S. insured persons by gender and age 2015
- Price disparities for top product Nexium - U.S. and international 2017
- Share of insured persons with prescription duration less than 90 days U.S. 2015
- Rate of opioid use disorder in insured US persons by dosage and duration 2015
- Opioid usage rate among persons with opioid use disorder in the U.S. 2015
- Revenue of top 20 respiratory brands in the U.S. 2016
- Actual need of opioids for everyone who is prescribed US 2017
- U.S. adults who who feared addiction to opioids 2017
- Opinion of US adults on opioid epidemic as an expression 2017
- U.S. adults who were prescribed unnecessary amount of opioids 2017, by gender
- Reasons for consumption of opioids by U.S. adults 2017
- U.S. adults who took opioids in last 2 years 2017
- Comparison of pre-expiry and generic price for drugs U.S. 2015
- U.S. sales for anagesic manufacturers in 2014/2015 and 2015/2016 by type
- Share of prescription opioid abusers in the U.S. 2011-2015, by age
- Common Medicaid gastrointestinal agent prescriptions by product 2013-2015
- Common Medicaid antipsychotic prescriptions by product 2013-2015
- Common Medicaid antidepressant prescriptions by product 2013-2015
- Revenue of top 20 neurology products in the U.S. 2016
- Drugs in development for selected autoimmune diseases U.S. 2016
- List of FDA approved drugs later pulled from market in the U.S. until 2014
- U.S. children and adult spending share on complementary health approaches 2012
- Usage of complementary health approaches in the U.S. 2002 and 2012 by ethnicity
- U.S. share of revenue-generating marijuana businesses being profitable 2016
- U.S. children and adults who spent on complementary health approaches by type 2012
- U.S. out-of-pocket per user expenditures on complementary health approaches 2012
- Number of U.S. adults who used nonvitamin, nonmineral dietary supplements 2012
- U.S. adult's most commonly used nonvitamin, nonmineral dietary supplements 2012
- Number of U.S. adult users of complementary health approaches in 2012, by ethnicity
- Most commonly used complementary health approaches share in the U.S. 2002 and 2012
- U.S. number of adult users of complementary health approaches in 2002 and 2012
- U.S. opinions on the effectiveness of homeopathy 2015, by age
- U.S. medical marijuana users that recommend cannabis 2016, by gender
- U.S. medical marijuana law effects on teenage marijuana usage by state 1995-2015
- U.S. states which approved specific diseases for treatment with marijuana
- U.S. medical marijuana dispensaries open 2015, by state
- Fewer annual drug doses in U.S. states with medical marijuana laws 2010-2013
- Sales forecast for eye care product Restasis in U.S. 2014-2025